Hospital Corporation of China (03869) Sets 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Final-Dividend Proposal

Bulletin Express
03/16

Hospital Corporation of China Limited (stock code: 03869) has notified the market that its Board of Directors will convene on 26 March 2026 in Hong Kong.

The agenda includes:

• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025. • Considering a recommendation on the payment of a final dividend, if any.

The announcement was authorised by Chairman Chen Shuai and dated 16 March 2026. The Board currently comprises three executive directors (Chen Shuai, Pu Chengchuan, Pan Jianli), two non-executive directors (Liu Lu, Wang Nan) and three independent non-executive directors (Dang Jinxue, Shi Luwen, Zhou Xiangliang).

No additional financial figures or dividend details were provided in the filing; these are expected upon the publication of the full FY 2025 results after the 26 March 2026 meeting.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10